PTPN11 and neoplasm: Enhanced immune-mediated tumor killing was observed in doxycycline-treated co-cultures, utilizing PBMCs from 3 separate donors, indicating that SHP2 depletion in cancer cells sensitizes them to immune-mediated killing (Fig. 1g).